Fexaramine,cas:574013-66-4
3-[3-[(cyclohexylcarbonyl)[[4-(dimethylamino)[1,1-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoic acid, methyl ester
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-XASYS-00508 | 10mg | 405.00 | + Add to cart |
|
| R-XASYS-00508 | 25mg | 778.00 | + Add to cart |
|
|
|
||||
Product description
Fexaramine(C32H36N2O3,496.6) is a novel, synthetic, small-molecule agonist of the farnesoid X receptor (FXR) that was first identified in 2011. It was initially developed as a potential therapeutic agent for metabolic diseases such as type 2 diabetes and non-alcoholic fatty liver disease. FXR is a nuclear hormone receptor that is found in the liver, intestine, and other tissues and is involved in the regulation of bile acid, glucose, and lipid metabolism.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Fexaramine
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


